Scaleable Production of Adenoviral Vectors by Transfection of Adherent PER.C6 Cells

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Biotechnology progress (Print)

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1021/bp0701620PMID 17715941
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pilot‐Scale Adenovirus Seed Production through Concurrent Virus Release and Concentration by Hollow Fiber Filtration

  2008cited by this paper
• The kinetics of adenovirus infection and spread in cell cultures infected with low multiplicity

  2005cited by this paper
• Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: toward a universal method for the facile quantitation of virus and vector potency.

  2005cited by this paper
• 100-liter transient transfection

  2004cited by this paper
• Calcium-phosphate mediated DNA transfer into HEK-293 cells in suspension: control of physicochemical parameters allows transfection in stirred media. Transfection and protein expression in mammalian cells

  2004cited by this paper
• Large-scale propagation of a replication-defective adenovirus vector in stirred-tank bioreactor PER.C6 cell culture under sparging conditions.

  2003cited by this paper
• Comparative Analysis of the Effects of Packaging Signal, Transgene Orientation, Promoters, Polyadenylation Signals, and E3 Region on Growth Properties of First-Generation Adenoviruses

  2003cited by this paper
• Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

  2002cited by this paper
• Virus-based vectors for human vaccine applications.

  2002cited by this paper
• Transient gene expression: recombinant protein production with suspension-adapted HEK293-EBNA cells.

  2001cited by this paper
• Calcium phosphate transfection optimization for serum-free suspension culture

  2001cited by this paper
• Rapid method for the isolation of full length adenoviral genomes by bacterial intermolecular homologous recombination.

  2001cited by this paper
• Gene therapy: the first decade.

  2000cited by this paper
• An improved anion-exchange HPLC method for the detection and purification of adenoviral particles

  2000cited by this paper
• Large-scale transient expression in mammalian cells for recombinant protein production.

  1999cited by this paper
• Comparison of manufacturing techniques for adenovirus production

  1999cited by this paper
• A simplified system for generating recombinant adenoviruses.

  1998cited by this paper
• A high-yielding serum-free, suspension cell culture process to manufacture recombinant adenoviral vectors for gene therapy

  1998cited by this paper
• New Helper Cells and Matched Early Region 1-Deleted Adenovirus Vectors Prevent Generation of Replication-Competent Adenoviruses

  1998cited by this paper
• Serum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cells.

  1998cited by this paper
• Analytical Anion-Exchange HPLC of Recombinant Type-5 Adenoviral Particles

  1997cited by this paper
• Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation.

  1996cited by this paper
• Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli

  1996cited by this paper
• Optimization of calcium phosphate transfection for bovine chromaffin cells: relationship to calcium phosphate precipitate formation.

  1995cited by this paper
• Optimization of Experimental Variables Influencing Reporter Gene Expression in Hepatoma Cells Following Calcium Phosphate Transfection

  1994cited by this paper
• High-efficiency transformation of mammalian cells by plasmid DNA.

  1987cited by this paper
• A new technique for the assay of infectivity of human adenovirus 5 DNA.

  1973cited by this paper

• Viruses and Virus-Like Particles in Biotechnology: Fundamentals and Applications

  2019cites this paper
• Advancements in mammalian cell transient gene expression (TGE) technology for accelerated production of biologics

  2018cites this paper
• Impaired antiviral response of adenovirus-transformed cell lines supports virus replication.

  2016cites this paper
• Impact of Adenovirus infection in host cell metabolism evaluated by (1)H-NMR spectroscopy.

  2016cites this paper
• Strategies for improved Adenovirus and PPR vaccine production in different cell lines

  2016influential citation
• Progress on adenovirus-vectored universal influenza vaccines

  2015cites this paper
• Large-scale adenovirus and poxvirus-vectored vaccine manufacturing to enable clinical trials.

  2015cites this paper
• Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines

  2012cites this paper
• Vaccine process technology

  2012cites this paper
• Viruses and Virus-Like Particles in Biotechnology

  2011cites this paper
• Adenovirus vector production and purification.

  2010cites this paper
• From the first to the third generation adenoviral vector: what parameters are governing the production yield?

  2009cites this paper
• Innovative vaccine production technologies: The evolution and value of vaccine production technologies

  2009cites this paper